Enveric Biosciences
Quarterly Financials
| Values in thousands | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $340 |
Gross Profit | -40 | -39 | -81 | -82 |
EBITDA | -1,833 | -2,479 | -2,103 | -3,064 |
EBIT | -1,873 | -2,519 | -2,184 | -3,147 |
Net Income | -1,873 | -2,519 | -2,184 | -3,154 |
Net Change In Cash | 0 | 0 | 0 | 340 |
Free Cash Flow | -2,074 | -1,890 | -2,391 | -1,311 |
Cash | 3,757 | 2,849 | 4,294 | 2,241 |
Basic Shares | 313 | 216 | 149 | 54 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -337 | -408 | -435 | -681 |
EBITDA | -9,228 | -16,854 | -19,516 | -55,739 |
EBIT | -9,566 | -17,262 | -19,952 | -56,421 |
Net Income | -9,574 | -17 | -18,504 | -48,976 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -7,726 | -14,099 | -17,730 | -12,322 |
Cash | 2,241 | 2,287 | 17,723 | 17,355 |
Basic Shares | 41 | 11 | 8 | 2 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-09-30 | -$10.81 |
2025-06-30 | -$11.65 |
2025-03-31 | -$4.81 |
2024-12-31 | -$0.17 |
